Rising Prevalence Of Gastrointestinal Disorders is Driving the Growth of the Global Gastrointestinal Endoscopy Market

The global gastrointestinal endoscopy market is experiencing steady growth, driven by the increasing prevalence of gastrointestinal disorders, advancements in endoscopic technologies, and a growing aging population. Gastrointestinal endoscopy plays a critical role in diagnosing and treating conditions such as colorectal cancer, gastrointestinal bleeding, inflammatory bowel disease, and ulcers. The demand for minimally invasive procedures is rising due to shorter recovery times, reduced hospital stays, and improved patient outcomes. Technological innovations, such as high-definition imaging, narrow-band imaging, and AI-assisted diagnostics, are enhancing diagnostic accuracy and procedural efficiency. Additionally, growing awareness about early disease detection and preventive healthcare is encouraging the adoption of routine endoscopic screenings. Hospitals, ambulatory surgical centers, and specialty clinics are major end-users, while key manufacturers focus on product innovation, training programs, and expanding their global footprint. However, the market also faces challenges including high costs of advanced equipment, limited access in low-resource settings, and stringent regulatory requirements. North America holds a significant share due to its robust healthcare infrastructure, while the Asia-Pacific region is emerging as a lucrative market owing to improving medical facilities and increasing patient awareness. Overall, the market is poised for growth, supported by rising healthcare investments and a continuous focus on technological development and service accessibility.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-gastrointestinal-endoscopy-market

Data Bridge Market Research analyzes that the Global Gastrointestinal Endoscopy Market, is expected to reach USD 18,798,321.84 thousand by 2032 from USD 12,066,210.00 thousand in 2024, growing at a substantial CAGR of 5.8% in the forecast period of 2025 to 2032.

Key Findings of the Study  

RISING PREVALENCE OF GASTROINTESTINAL DISORDERS

Gastrointestinal (GI) disorders such as colorectal cancer, gastroesophageal reflux disease (GERD), Crohn’s disease, and ulcerative colitis have been rising steadily, becoming a major driver for the gastrointestinal endoscopy market. These conditions often require early and accurate diagnosis, for which endoscopy remains a primary tool. Colorectal cancer, for instance, ranks among the top causes of cancer-related deaths worldwide, and regular endoscopic screenings like colonoscopies are vital for early detection and prevention. Similarly, chronic GI diseases like Crohn’s and GERD necessitate ongoing endoscopic evaluation for disease management and monitoring. The growing prevalence of these conditions, coupled with improved awareness and accessibility of healthcare services, is leading to a surge in demand for gastrointestinal endoscopic procedures across both developed and emerging economies

Report Scope and Market Segmentation

Segment Analysis

The global gastrointestinal endoscopy market is categorized into five notable segments based on product, procedure type, usability, end user, and distribution channel.

• On the basis of product, the market is segmented into gastrointestinal endoscopes & systems, gastrointestinal endotherapy. The gastrointestinal endoscopes & systems is further segmented into endoscopes, visualization systems, endoscopic ultrasonography systems, capsule endoscopes, and ultrasound device. The endoscopes is further segmented into colonoscopes, gastroscopes, duodenoscopes, enteroscopes, sigmoidscopes, resectoscopes, others. The endoscopes is further segmented into flexible, rigid, and semi rigid. The endoscopes is further segmented into video, fibre, and ultrasonic. The visualization systems is further segmented into fluorescence imaging systems and confocal laser endoscopy imaging systems. The fluorescence imaging systems is further segmented into NIR light fluorescence imaging system, white light fluorescence imaging system, UV light fluorescence imaging systems. The confocal laser endoscopy imaging systems is further segmented into Probe-Based CLE (pCLE), Built-In Device CLE (eCLE). The Standard Definition (SD) visualization systems is further segmented into 2D systems, 3D systems. The gastrointestinal endotherapy is further segmented into ERCP devices, biopsy device, stenting and dilation device, Homeostasis devices, retrieval devices, camera head, anti-reflux devices, others. The homeostasis devices is further segmented into ligation devices, probes, sclerotherapy neeedles. The anti-reflux devices is further segmented into Transoral Incisionless Fundoplication (TIF) devices, transesophageal Radiofrequency (RF) anti-reflux devices.

In 2025, the gastrointestinal endoscopes & systems segment is expected to dominate the market

In 2025, the gastrointestinal endoscopes & systems segment is expected to dominate the market with a market share a 58.03% due to rising demand for minimally invasive procedures, growing prevalence of digestive disorders, and technological advancements. Enhanced imaging capabilities and integration with AI-driven diagnostic tools further drive adoption across hospitals and clinics, reinforcing its leading market position.

• On the basis of application, the market is segmented into treatment and diagnosis

In 2025, the treatment segment is expected to dominate the market

In 2025 the treatment segment is expected to dominate the market with a market share of a 56.34% due to increasing cases of gastrointestinal diseases requiring therapeutic intervention. Advancements in endoscopic treatment technologies, rising preference for minimally invasive procedures, and growing awareness among patients and physicians are driving demand, positioning this segment as a key market leader.

• On the basis of procedure type, the market is segmented into colonoscopy, gastroscopy, duodenoscopy, enteroscopy, sigmoidoscopy and others. In 2025, the colonoscopy segment is expected to dominate the market with a market share a 41.20%
• On the basis of usability, the market is segmented into reusable, disposable/ single use. In 2025, the reusable segment is expected to dominate the market with a market share a 69.44%
• On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, laboratories, and others. In 2025, the hospitals segment is expected to dominate the market with a market share with a 53.26%
• On the basis of distribution channel, the market is segmented into direct tender, retail sales, and others. In 2025, the direct tender segment is expected to dominate the market with a market share with a 63.66%

Major Players

Data Bridge Market Research analyzes Medtronic (Ireland), Stryker (U.S.), Johnson & Johnson Services, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cook (U.S.) as the major market players of the market.

Market Development

• In January 2025, Olympus Corporation announced the completion of its acquisition of Taewoong Medical Co., Ltd., a South Korea-based manufacturer specializing in gastrointestinal (GI) metallic stents. This strategic move enhances Olympus' GI EndoTherapy product portfolio, enabling the company to offer comprehensive solutions for treating conditions in the biliary tract, esophagus, colon, and duodenum. The acquisition, valued at approximately USD 370 million, integrates Taewoong Medical into Olympus’ Therapeutic Solutions Division, reinforcing its commitment to improving patient outcomes and elevating the standard of care in the GI market.
• In March 2024, FUJIFILM received 510(k) clearance for CAD EYE, its AI-powered detection system that aids in real-time identification of colonic lesions during colonoscopy. Integrated with the ELUXEO platform, CAD EYE uses deep learning to highlight hard-to-see polyps with visual and auditory alerts, enhancing detection accuracy without disrupting clinical workflows.
• In February 2022, Medtronic, in partnership with ASGE and AWS, has launched the Health Equity Assistance Program to provide 50 GI Genius endoscopy modules for colorectal cancer screening in underserved U.S. communities. The initiative aims to improve early detection, particularly in high-risk groups, and impact over 350,000 patients over three years.
• In May 2022, Ambu A/S launched the world's first gastroscope with a bioplastic handle, derived from recycled food waste. This initiative aims to reduce the carbon footprint of endoscopic devices, aligning with Ambu's sustainability goals.
• In February 2023, AnX Robotica launches the FDA-cleared NaviCam Small Bowel System in the U.S., featuring aspherical lens technology for enhanced imaging and reduced distortion. With faster download and processing times, the system improves diagnostic efficiency for small bowel diseases, supporting timely evaluation of obscure GI bleeding and inflammatory bowel disease (IBD).
• In August 2024, Boston Scientific launched the AXIOS Stent with Electrocautery Enhanced Delivery System for endoscopic gallbladder drainage in acute cholecystitis patients unsuitable for surgery. Using EUS guidance, it enables internal bile drainage, avoiding external drains. Clinical studies show fewer complications and faster recovery compared to traditional methods, offering a minimally invasive option for high-risk patients,.

Regional Analysis

Geographically, the countries covered in the Global Gastrointestinal Endoscopy Market report are (U.S., Canada, Mexico, Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Netherlands, Switzerland, And Rest Of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, Rest Of Asia-Pacific, Brazil, Argentina, And Rest Of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Kuwait, Israel, And Rest Of Middle East And Africa.

As per Data Bridge Market Research analysis:

North America is the dominant region in the Global Gastrointestinal Endoscopy Market during the forecast period of 2025 to 2032

North America is expected to dominate the market due to advanced healthcare infrastructure, high adoption of cutting-edge technologies, significant research and development investments, strong healthcare reimbursement policies, and a growing aging population. North America will continue to dominate the market in terms of market share and revenue and flourish its dominance during the forecast period.

Asia-Pacific is estimated to be the fastest-growing region in the Global Gastrointestinal Endoscopy Market during the forecast period of 2025 to 2032.

Asia-Pacific is expected to grow during the forecast period due to increasing healthcare investments, expanding healthcare infrastructure, rising awareness, and a large aging population.

For more detailed information about the Global Gastrointestinal Endoscopy Market report, click here – https://www.databridgemarketresearch.com/reports/global-gastrointestinal-endoscopy-market